PHARMA SPONSOR ENLISTS CENDUIT TO RESCUE A MULTI-COUNTRY, MULTI-SITE ONCOLOGY STUDY: Achieves Seamless Transition to Cenduit IRT Mid-Study Execution,
PHARMA SPONSOR ENLISTS CENDUIT TO RESCUE A MULTI-COUNTRY, MULTI-SITE ONCOLOGY STUDY: Achieves Seamless Transition to Cenduit IRT Mid-Study Execution,
3 PagesPHARMA SPONSOR ENLISTS CENDUIT TO RESCUE A MULTI-COUNTRY, MULTI-SITE ONCOLOGY STUDY: Achieves Seamless Transition to Cenduit IRT Mid-Study Execution, while Maintaining Study Timelines The following case study describes an oncology rescue study– achieving Go-Live within the original timeframe, and exceeding expectations in navigating trial complexity.Study Overview The sponsor assessed the safety and tolerability of escalating oral doses of one drug, when combined with the standard dosing of another, in patients with advanced solid malignancies. The client: a global pharmaceutical group focused on developing prescription drugs that target unmet medical needs in numerous indications including oncology. Challenge: Adaptive Design, • After go-live, the sponsor learned its study
